APA

Modest D. P., Denecke T., Pratschke J., Ricard I., Lang H., Bemelmans M., Becker T., Rentsch M., Seehofer D., Bruns C. J., Gebauer B., Modest H. I., Held S., Folprecht G., Heinemann V. & Neumann U. P. (20180813). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. : European journal of cancer (Oxford, England : 1990).

Chicago

Modest D P, Denecke T, Pratschke J, Ricard I, Lang H, Bemelmans M, Becker T, Rentsch M, Seehofer D, Bruns C J, Gebauer B, Modest H I, Held S, Folprecht G, Heinemann V and Neumann U P. 20180813. Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. : European journal of cancer (Oxford, England : 1990).

Harvard

Modest D. P., Denecke T., Pratschke J., Ricard I., Lang H., Bemelmans M., Becker T., Rentsch M., Seehofer D., Bruns C. J., Gebauer B., Modest H. I., Held S., Folprecht G., Heinemann V. and Neumann U. P. (20180813). Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. : European journal of cancer (Oxford, England : 1990).

MLA

Modest D P, Denecke T, Pratschke J, Ricard I, Lang H, Bemelmans M, Becker T, Rentsch M, Seehofer D, Bruns C J, Gebauer B, Modest H I, Held S, Folprecht G, Heinemann V and Neumann U P. Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3. : European journal of cancer (Oxford, England : 1990). 20180813.